Older age is associated with similar quality of life and physical function compared to younger age during intensive chemotherapy for acute myeloid leukemia

Leukemia Research

Volumn 36, Issue 10, 2012, Pages 1241-1248

  Mohamedali, H ^a   Breunis, H ^a   Timilshina, N ^a   Brandwein, J M ^a,c   Gupta, V ^a,c   Li, M ^a,c   Tomlinson, G ^a,c   Buckstein, R ^b,c   Alibhai, S M H ^a,c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Acute myeloid leukemia; Aging; Chemotherapy; Fatigue; Physical function; Quality of life

Indexed keywords

AMSACRINE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MITOXANTRONE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE DISTRIBUTION; AGED; AGING; ARTICLE; CANCER CHEMOTHERAPY; COHORT ANALYSIS; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG TOLERABILITY; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; LEUKEMIA REMISSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NORMAL VALUE; OUTCOME ASSESSMENT; PHYSICAL CAPACITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; TREATMENT DURATION;

ACTIVITIES OF DAILY LIVING; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; DAUNORUBICIN; FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84865162409     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2012.05.020     Document Type: Article

References (27)

1. Grimwade D., Walker H., Harrison G., Oliver F., Chatters S., Harrison C.J., et al. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 2001, 98:1312-1320.
2. Stalfelt A.M. Quality of life during induction treatment of acute myeloid leukaemia. A comparison of three intensive chemotherapy regimens using three instruments for quality of life assessment. Acta Oncol 1994, 33:477-485.
3. Schumacher A., Kessler T., Buchner T., Wewers D., van de Loo J. Quality of life in adult patients with acute myeloid leukemia receiving intensive and prolonged chemotherapy - a longitudinal study. Leukemia 1998, 12:586-592.
4. Estey E.H., General approach to and perspectives on clinical research in, older patients with newly diagnosed acute myeloid leukemia. Semin Hematol 2006, 43:89-95.
5. Sawhney R., Sehl M., Naeim A. Physiologic aspects of aging: impact on cancer management and decision making, part I. Cancer J 2005, 11:449-460.
6. Sehl M., Sawhney R., Naeim A. Physiologic aspects of aging: impact on cancer management and decision making, part II. Cancer J 2005, 11:461-473.
7. Menzin J., Lang K., Earle C.C., Kerney D., Mallick R. The outcomes and costs of acute myeloid leukemia among the elderly. Arch Intern Med 2002, 162:1597-1603.
8. Alibhai S.M., Leach M., Minden M.D., Brandwein J. Outcomes and quality of care over 4 decades for patients with acute myeloid leukemia. Cancer 2009, 115:2903-2911.
9. Aaronson N.K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N.J., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85:365-376.
10. Cella D. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 1997, 34:13-19.
11. Bruera E., Kuehn N., Miller M.J., Selmser P., Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J. Palliative Care 1991, 7:6-9.
12. Mathiowetz V., Kashman N., Volland G., Weber K., Dowe M., Rogers S. Grip and pinch strength: normative data for adults. Arch Phys Med Rehabil 1985, 66:69-74.
13. Onder G., Penninx B.W., Ferrucci L., Fried L.P., Guralnik J.M., Pahor M. Measures of physical performance and risk for progressive and catastrophic disability: results from the Women's Health and Aging Study. J Gerontol A Biol Sci Med Sci 2005, 60:74-79.
14. Rantanen T., Volpato S., Ferrucci L., Heikkinen E., Fried L.P., Guralnik J.M. Handgrip strength and cause-specific and total mortality in older disabled women: exploring the mechanism. J Am Geriatr Soc 2003, 51:636-641.
15. McArdle W.D., Katch F.I., Pechar G.S., Jacobson L., Ruck S. Reliability and interrelationships between maximal oxygen intake, physical work capacity and step-test scores in college women. Med Sci Sports Exerc 1972, 4:182-186.
16. Finch E., Brooks D., Stratford P., Mayo N. Physical rehabilitation outcome measures II 2002, Canadian Physiotherapy Association, Toronto. second ed.
17. Solway S., Brooks D., Lacasse Y., Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001, 119:256-270.
18. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
19. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1990, 1:43-46.
20. Donaldson G.W., Moinpour C.M. Learning to live with missing quality-of-life data in advanced-stage disease trials. J Clin Oncol 2005, 23:7380-7384.
21. Fairclough D.L. Analysing studies with missing data. Assessing quality of life in clinical trials: methods and practice 2005, Oxford University Press, Oxford. 2nd ed. P. Fayers, R. Hays (Eds.).
22. King M.T. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 1996, 5:555-567.
23. Hjermstad M.J., Fayers P.M., Bjordal K., Kaasa S. Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire: the QLQ=C30 (+3). J Clin Oncol 1998, 16:1188-1196.
24. Cella D., Lai J.S., Chang C.H., Peterman A., Slavin M. Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 2002, 94:528-538.
25. Redelmeier D.A., Bayoumi A.M., Goldstein R.S., Guyatt G.H. Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997, 155:1278-1282.
26. Ling C.H., Taekema D., de Craen A.J., Gussekloo J., Westendorp R.G., Maier A.B. Handgrip strength and mortality in the oldest old population: the Leiden 85-plus study. CMAJ 2010, 182:429-435.
27. Alibhai S.M.H., Leach M., Kermalli H., Gupta V., Kowgier M.E., Tomlinson G.A., et al. The impact of acute myeloid leukemia and its treatment on quality of life and functional status in older adults. Crit Rev Oncol Hematol 2007, 64:19-30.